Pulmatrix (PULM) vs Redhill Biopharma (RDHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Pulmatrix is the larger company by market cap ($5.4 million vs $4.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PULM | RDHL |
|---|---|---|
| Share price | $1.47 | $0.5451 |
| Market cap | $5.37M | $4.84M |
| 1-day change | -3.74% | -5.69% |
| Forward P/E | — | 18.17 |
| EPS (TTM) | $-1.10 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.24 | $2.14 |
| 52-week low | $1.16 | $0.435 |
| Distance from 52-week high | -71.92% | -74.53% |
| Average volume | 24.09K | 2.05M |
| Shares outstanding | 3.65M | 8.89M |
| Employees | 2 | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Pulmatrix
PULM stock →Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
About Redhill Biopharma
RDHL stock →RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
PULM vs RDHL FAQ
Which is bigger, Pulmatrix or Redhill Biopharma?
Pulmatrix (PULM) is larger, with a market capitalization of $5.37M compared with $4.84M for Redhill Biopharma (RDHL).
Are Pulmatrix and Redhill Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.